SCHEMBL6265288

SCHEMBL6265288

CCCCCCCCCCCCCCSCC(O)=S

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.63
HSD17B10 Q99714 2/20 0.63
GMNN O75496 1/20 0.63
TP53 P04637 1/20 0.63
POLB P06746 1/20 0.63
MAPT P10636 1/20 0.63
CYP2C9 P11712 1/20 0.63
BLM P54132 1/20 0.63
CES2 O00748 3/20 0.57
CES1 P23141 5/20 0.50
FAAH O00519 4/20 0.50
PLA2G6 O60733 1/20 0.50
CA2 P00918 1/20 0.41
PLA2G4B P0C869 2/20 0.37
TSHR P16473 2/20 0.36
MGLL Q99685 1/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405335 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
Tetradecylthioacetic Acid SCHEMBL7524926 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL4814083 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL4649866 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
Tetradecylthioacetic Acid SCHEMBL207756 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL3638014 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL939761 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL10491282 0.77 HSD17B10 (0.63) THRBHSD17B10GMNNTP53POLB
SCHEMBL1405316 0.77 HSD17B10 (1.00) THRBHSD17B10GMNNTP53POLB
SCHEMBL24362145 0.74 THRB (0.57) THRBHSD17B10GMNNTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1596845-A1 THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF Genfit (FR) 2005-11-23 EP disclosed
EP-1587508-A1 THERAPEUTIC USE OF ACYLGLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEREOF Genfit (FR) 2005-10-26 EP disclosed
WO-2004073698-A1 THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF GENFIT (FR) 2004-09-02 WO disclosed
WO-2004069241-A1 THERAPEUTIC USE OF ACYLGLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEREOF GENFIT (FR) 2004-08-19 WO disclosed